from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0581/vapB26

LFCtreatmentdescriptionclass of inhibitor

1.546

Amikacinug/mL Amikacintranslation

-0.285

Cap5-10ug/mL Capreomycintranslation

0.946

Rox10-50 ug/mL Roxithromycintranslation

0.442

SM2-5 ug/mL Streptomycintranslation

1.207

Tet5-10 ug/mL Tetracyclinetranslation

-0.953

Rif0.2-5ug/mL Rifampicintranscription

-0.293

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.669

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.084

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.120

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.557

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.272

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.109

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.668

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.446

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.500

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.317

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.243

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.063

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.656

KCN5-20 ug/mL Potassium cyaniderespiration

-0.210

NaN30.2-2 mM Sodium aziderespiration

-1.531

Nigericin50 uM Nigericinrespiration

0.729

TRC10-150 ug/mL Triclosanrespiration

0.178

TRZ10-25 ug/mL Thioridazinerespiration

1.182

Valinomycin0.5-10 uM Valinomycinrespiration

-0.711

ZnSO42 mM ZnSO4respiration

0.045

menadione6-10 ug/mL Menadionerespiration

-0.444

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.192

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.465

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.028

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.120

NRP_1Non-replicating persistence stage 1dosRassociated

0.123

Amp0.2mg/mL AmpicillincellWall

0.508

Cephalexin20-100 ug/mL CephalexincellWall

-0.484

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.483

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.338

EMB10-20 ug/mL EthambutolcellWall

0.559

Eta12-40 ug/mL EthionamidecellWall

1.028

INH0.2-0.4 ug/mL IsoniazidcellWall

0.082

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.189

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.151

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.973

BZA0.12 mg/mL BenzamidearomaticAmides

1.332

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.125

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.272

H2O24 mM hydrogen peroxideDNAdamaging

0.003

Levo10 ug/mL LevofloxacinDNAdamaging

-1.040

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.286

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.089

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.586

UVUV-irradiationDNAdamaging

-0.640

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.351

Antimycin12.5-50 ug/mL Antimycin A?

-0.167

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.525

PA_110-50 ug/mL Antitubercular compound PA-1?

0.110

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.086

PA8240.2-2 ug/mL PA-824?

-0.110

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.258

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.503

Verapamil50 uM Verapamil?

-0.767

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.330

methoxatin10-20 ug/mL Methoxatin?